Demant A/S Unsponsored ADR (OTCMKTS:WILYY) Short Interest Down 28.9% in March

Key Points

• Short interest down 28.9% in March to 118 shares (0.0% of shares sold short), with a short-interest ratio of 2.5 days based on average daily volume of 48 shares.
• Jefferies upgraded Demant from "hold" to "strong-buy" on March 18; overall analyst mix is two Strong Buy ratings and one Hold, giving an average "Buy" rating.
• Shares opened at $14.96, trading within a 1‑year range of $13.45–$21.93; the 50‑day moving average ($14.17) sits below the 200‑day average ($16.15), and the company reports a current ratio of 1.36, quick ratio of 1.00 and debt‑to‑equity of 1.65.

Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totaling 118 shares, a drop of 28.9% from the March 15th total of 166 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 48 shares, the short-interest ratio is currently 2.5 days.

Demant A/S Stock Performance

OTCMKTS:WILYY opened at $14.96 on Tuesday. Demant A/S has a 1-year low of $13.45 and a 1-year high of $21.93. The company's fifty day moving average price is $14.17 and its 200-day moving average price is $16.15. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 1.65.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised shares of Demant A/S from a "hold" rating to a "strong-buy" rating in a report on Wednesday, March 18th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Buy".

About Demant A/S

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company's flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant's product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.